Evolva Holding SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Evolva Holding SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4102
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥45,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥68,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Evolva Holding SA – Strategy, SWOT and Corporate Finance Report
Summary

Evolva Holding SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Evolva Holding SA (Evolva) is a biotechnology company that discovers and develops ingredients for the consumer healthcare, nutrition and pharmaceutical market. The company’s product portfolio includes resveratrol, components of vanilla, stevia and saffron; Pomecins, the compound used primarily for food and crop protection, and Valencene, an orange flavor and fragrance ingredient used in food and beverage, personal care and household products. Those products are marketed through Veri-te Resveratrol, EveNootkatone, EveValencene, and EverSweet Stevia brands.The company offers products online through e-commerce platform, shop.evolva.com. Evolva has business presence in the US, the UK, Switzerland, Denmark and India. Evolva is headquartered in Reinach, Aargau, Switzerland.

Scope

- Detailed information on Evolva Holding SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Evolva Holding SA in the form of a SWOT analysis
- An in-depth view of the business model of Evolva Holding SA including a breakdown and examination of key business segments
- Intelligence on Evolva Holding SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Evolva Holding SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Evolva Holding SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Evolva Holding SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Evolva Holding SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Evolva Holding SA: Company Overview 9
Evolva Holding SA: Overview and Key Facts 9
Evolva Holding SA: Overview 9
Evolva Holding SA: Key Facts 9
Evolva Holding SA: Key Employees 11
Evolva Holding SA: Key Employee Biographies 12
Evolva Holding SA: Major Products and Services 14
Evolva Holding SA: Company History 15
Evolva Holding SA: Management Statement 19
Evolva Holding SA: Locations and Subsidiaries 20
Evolva Holding SA: Key Competitors 22
Evolva Holding SA: Company Analysis 23
Evolva Holding SA: Business Description 23
Evolva Holding SA: SWOT Analysis 25
Evolva Holding SA: SWOT Overview 25
Evolva Holding SA: Strengths 25
Evolva Holding SA: Weaknesses 26
Evolva Holding SA: Opportunities 26
Evolva Holding SA: Threats 27
Evolva Holding SA: Corporate Financial Deals Activity 29
Evolva Holding SA: Financial Deals Overview 29
Evolva Holding SA: Targets and Partners 30
Evolva Holding SA: Top Deals 2014 – 2018YTD* 31
Evolva Holding SA: Partnership 32
Evolva Holding SA: Recent Developments 33
Evolva Holding SA: News and Events Summary 33
Evolva Holding SA: Corporate Governance 35
Evolva Holding SA: Financial Deals 36
Evolva Holding SA: Financial Performance 36
Evolva Holding SA: Grants 37
Evolva Holding SA: Red Flags/DistressSignals 37
Evolva Holding SA: Regulatory and Legal Events 37
Evolva Holding SA: Research & Development 38
Evolva Holding SA: Strategy and Operations 38
Appendix 40
Contact Us 40
Methodology 40
About MarketLine 41

List of Tables
Table 1: Evolva Holding SA: Key Facts
Table 2: Evolva Holding SA: Key Employees
Table 3: Evolva Holding SA: Locations and Subsidiaries
Table 4: Evolva Holding SA: Key Competitors
Table 5: Evolva Holding SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Evolva Holding SA: Targets and Partners
Table 7: Evolva Holding SA: Top Deals 2014 - 2018YTD*
Table 8: Evolva Holding SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 9: Evolva Holding SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 10: Evolva Holding SA: News and Events Summary
Table 11: Evolva Holding SA: Corporate Governance
Table 12: Evolva Holding SA: Financial Deals
Table 13: Evolva Holding SA: Financial Performance
Table 14: Evolva Holding SA: Grants
Table 15: Evolva Holding SA: Red Flags/DistressSignals
Table 16: Evolva Holding SA: Regulatory and Legal Events
Table 17: Evolva Holding SA: Research & Development
Table 18: Evolva Holding SA: Strategy and Operations

List of Figures
Figure 1: Evolva Holding SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Evolva Holding SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 3: Evolva Holding SA: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Evolva Holding SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Robert Half International Inc. (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc. (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Avillion LLP-製薬・医療分野:企業M&A・提携分析
    Summary Avillion LLP (Avillion) is a provider of drug development services. The company supports pharmaceutical and biotechnology companies to develop drug candidates without increasing the burden on them. It maintains a business model for the clinical development and regulatory approval of late sta …
  • Prismic Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a pharmaceutical company that provides research and development of prescription drugs which has unique safety profiles. The company develops drugs for inflammatory diseases and oxidative stress disorders. It pipeline products are used …
  • Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析
    Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Enmax Corp:企業の戦略的SWOT分析
    Enmax Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Oncobiologics Inc (ONS):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncobiologics Inc (Oncobiologics) is a clinical stage biopharmaceutical company that identifies, develops, manufactures and commercializes biosimilar therapeutics in the areas of immunology and oncology. The company's pipeline products include ONS-3010, an adalimumab biosimilar intended for …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Airest S.p.A.:企業の戦略・SWOT・財務分析
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Spotlight Innovation Inc (STLT):企業の財務・戦略的SWOT分析
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Marafiq:企業の発電所・SWOT分析2018
    Marafiq - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Symic Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation. The company’s ECM specific compounds facilitate local application, which enhances its a …
  • Warp Drive Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Warp Drive Bio Inc (Warp Drive) is an inventor of therapeutic agents that exploits molecules and createstransformative medicines through nature. The company utilizes its proprietary genomic mining and small molecule assisted receptor targeting platform to develop novel medicines. Its SMART p …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Quarterhill Inc.:企業のM&A・事業提携・投資動向
    Quarterhill Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quarterhill Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • SynergEyes Inc-医療機器分野:企業M&A・提携分析
    Summary SynergEyes Inc (SynergEyes) is a medical device company that offers contact lenses. The company offers hybrid contact lenses to transform vision for patients with astigmatism, presbyopia, presbyopia, myopia, hyperopia, keratoconus, and other eye conditions. It provides ultrahealth hybrid len …
  • Envases Del Plata S.A.
    Envases Del Plata S.A. - Strategy, SWOT and Corporate Finance Report Summary Envases Del Plata S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Visaka Industries Ltd:企業の戦略・SWOT・財務情報
    Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Industriens Pensionsforsikring AS:電力:M&Aディール及び事業提携情報
    Summary Industriens Pensionsforsikring AS (Industriens Pensionsforsikring) is an insurance service provider. The company offers member pension insurance and company pension insurance products. Its member pension insurance covers critical illness, loss of earning capacity, death, healthcare, insuranc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆